Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model
E. J. Sanderlin, M. Marie, J. Velcicky, P. Loetscher, L. V. Yang
This study shows that inhibiting GPR4 with antagonist 13 reduces intestinal inflammation in a DSS-induced colitis mouse model by improving clinical and histopathological outcomes.
bioRxiv · Jan 29, 2019Pharmacology & Toxicology